These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1714857)

  • 1. Anti idiotypic recognition of auto and allo antibodies to factor VIII by immunoglobulin preparations from single blood donors and large plasma pool.
    Sultan Y; Rossi F; Kazatchkine M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):539-43. PubMed ID: 1714857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-idiotypes against autoantibodies and alloantibodies to VIII:C (anti-haemophilic factor) are present in therapeutic polyspecific normal immunoglobulins.
    Rossi F; Sultan Y; Kazatchkine MD
    Clin Exp Immunol; 1988 Nov; 74(2):311-6. PubMed ID: 3147154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin.
    Sultan Y; Kazatchkine MD; Maisonneuve P; Nydegger UE
    Lancet; 1984 Oct; 2(8406):765-8. PubMed ID: 6148519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery from anti-VIII:C (antihemophilic factor) autoimmune disease is dependent on generation of antiidiotypes against anti-VIII:C autoantibodies.
    Sultan Y; Rossi F; Kazatchkine MD
    Proc Natl Acad Sci U S A; 1987 Feb; 84(3):828-31. PubMed ID: 3101065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monoclonal anti-idiotypic antibody against the antigen-combining site of anti-factor VIII autoantibodies defines and idiotope that is recognized by normal human polyspecific immunoglobulins for therapeutic use (IVIg).
    Dietrich G; Pereira P; Algiman M; Sultan Y; Kazatchkine MD
    J Autoimmun; 1990 Oct; 3(5):547-57. PubMed ID: 1701301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Origin of anti-idiotypic activity against anti-factor VIII autoantibodies in pools of normal human immunoglobulin G (IVIg).
    Dietrich G; Algiman M; Sultan Y; Nydegger UE; Kazatchkine MD
    Blood; 1992 Jun; 79(11):2946-51. PubMed ID: 1586740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies.
    Dietrich G; Kazatchkine MD
    J Clin Invest; 1990 Mar; 85(3):620-5. PubMed ID: 2312717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig.
    Rossi F; Kazatchkine MD
    J Immunol; 1989 Dec; 143(12):4104-9. PubMed ID: 2592768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-idiotypes against antiphospholipid antibodies are present in normal polyspecific immunoglobulins for therapeutic use.
    Caccavo D; Vaccaro F; Ferri GM; Amoroso A; Bonomo L
    J Autoimmun; 1994 Aug; 7(4):537-48. PubMed ID: 7980854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor VIII Inhibitors. Natural autoantibodies and anti-idiotypes.
    Gilles JG; Vanzieleghem B; Saint-Remy JM
    Semin Thromb Hemost; 2000; 26(2):151-5. PubMed ID: 10919407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural antibodies to factor VIII.
    Lacroix-Desmazes S; Moreau A; Pashov A; Sooryanarayana ; Stahl D; Saint-Remy JM; Kaveri SV; Kazatchkine MD
    Semin Thromb Hemost; 2000; 26(2):157-65. PubMed ID: 10919408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo clearing of idiotypic antibodies with antiidiotypic antibodies and their derivatives.
    Erlandsson A; Eriksson D; Johansson L; Riklund K; Stigbrand T; Sundström BE
    Mol Immunol; 2006 Feb; 43(6):599-606. PubMed ID: 15978666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunochemical characterization of factor VIII inhibitors.
    Hoyer LW; Gawryl MS; de la Fuente B
    Prog Clin Biol Res; 1984; 150():73-85. PubMed ID: 6431443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-idiotypes against autoantibodies to procoagulant factor VIII (VIII:C) in intravenous immunoglobulins.
    Kazatchkine MD; Rossi F; Sultan Y; Nydegger U
    Int Rev Immunol; 1989; 5(2):157-63. PubMed ID: 8691048
    [No Abstract]   [Full Text] [Related]  

  • 15. Idiotypic regulation of anti-factor VIII antibodies.
    Kazatchkine MD; Lacroix-Desmazes S; Moreau A; Kaveri SV
    Haematologica; 2000 Oct; 85(10 Suppl):97-9. PubMed ID: 11187885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiotypic network: possible explanation of seronegativity in a patient with rheumatoid arthritis.
    Pasquali JL; Urlacher A; Storck D
    Clin Exp Immunol; 1984 Feb; 55(2):281-6. PubMed ID: 6697565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthy subjects produce both anti-factor VIII and specific anti-idiotypic antibodies.
    Gilles JG; Saint-Remy JM
    J Clin Invest; 1994 Oct; 94(4):1496-505. PubMed ID: 7523452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of auto-anti-idiotypic antibody during the normal human immune response to tetanus toxoid antigen.
    Geha RS
    J Immunol; 1982 Jul; 129(1):139-44. PubMed ID: 7086128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired inhibitors.
    Cohen AJ; Kessler CM
    Baillieres Clin Haematol; 1996 Jun; 9(2):331-54. PubMed ID: 8800509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of circulating anti-idiotype-bearing cells after booster immunization with tetanus toxoid (TT) and inhibition of anti-TT antibody synthesis by auto-anti-idiotypic antibody.
    Geha RS
    J Immunol; 1983 Apr; 130(4):1634-9. PubMed ID: 6601133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.